You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

INCMGA0012

Showing 1 - 15 of 15
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Unresectable Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Merkel Cell Carcinoma AJCC v8, Merkel Cell

Not yet recruiting
  • Unresectable Clinical Stage III Merkel Cell Carcinoma AJCC v8
  • +2 more
  • Biopsy
  • +6 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 28, 2023

Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma, Metastatic Triple-Negative Breast Carcinoma Trial in

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +4 more
  • Pelareorep
  • +3 more
  • New Brunswick, New Jersey
  • +1 more
Sep 26, 2022

Advanced Neuroendocrine Tumor, Carcinoid Syndrome Trial (Retifanlimab, Telotristat Ethyl)

Withdrawn
  • Advanced Neuroendocrine Neoplasm
  • Carcinoid Syndrome
  • Retifanlimab
  • Telotristat Ethyl
  • (no location specified)
Sep 23, 2021

DLBCL, Grade 3b Follicular Lymphoma, High Grade B-Cell Lymphoma Trial in Seattle (procedure, drug, biological)

Not yet recruiting
  • Diffuse Large B-Cell Lymphoma
  • +2 more
  • Biopsy
  • +7 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 12, 2022

Penile Cancer Trial in Italy, Spain (INCMGA0012)

Active, not recruiting
  • Penile Cancer
  • INCMGA0012
  • Milano, Italy
  • +12 more
Jan 18, 2023

Advanced Malignancies Trial in Worldwide (Pemigatinib, Retifanlimab, Pembrolizumab)

Recruiting
  • Advanced Malignancies
  • Santa Monica, California
  • +6 more
Apr 6, 2022

Locally Advanced Solid Tumors, Metastatic Solid Tumors Trial in Worldwide (retifanlimab)

Active, not recruiting
  • Locally Advanced Solid Tumors
  • Metastatic Solid Tumors
  • Scottsdale, Arizona
  • +79 more
Nov 9, 2022

Advanced Solid Tumors Trial in Worldwide (INCB081776, INCMGA00012)

Recruiting
  • Advanced Solid Tumors
  • New Haven, Connecticut
  • +19 more
Nov 10, 2022

Endometrial Cancer Trial in Worldwide (retifanlimab, epacadostat, pemigatinib)

Recruiting
  • Endometrial Cancer
  • Anchorage, Alaska
  • +78 more
Jul 25, 2022

Ovarian Cancer, Bladder Cancer, Non Small Cell Lung Cancer Trial in Worldwide (INCB106385, INCMGA00012)

Recruiting
  • Ovarian Cancer
  • +10 more
  • West Hollywood, California
  • +27 more
Jun 27, 2022

Advanced Solid Tumors, Metastatic Solid Tumors Trial in Chuo Ku, Kashiwa (Retifanlimab, INCB001158, Retifanlimab + INCB001158)

Completed
  • Advanced Solid Tumors
  • Metastatic Solid Tumors
  • Chuo Ku, Japan
  • +1 more
Feb 24, 2022

Squamous Cell Carcinoma of Anal Canal Trial in Worldwide (Retifanlimab)

Completed
Has Results
  • Squamous Cell Carcinoma of Anal Canal
  • Duarte, California
  • +46 more
Jan 11, 2022

Squamous Cell Carcinoma of the Anal Canal Trial in Worldwide (carboplatin, paclitaxel, retifanlimab)

Recruiting
  • Squamous Cell Carcinoma of the Anal Canal
  • Tucson, Arizona
  • +85 more
Jun 13, 2022

NSCLC Trial (Retifanlimab, Placebo, Pemetrexed)

Withdrawn
  • Non-small Cell Lung Cancer
  • (no location specified)
Jun 5, 2020

Advanced and/or Metastatic Solid Tumors, Stage IIIB Not Amenable to Curative Therapy to Stage IV NSCLC, Advanced/Metastatic

Withdrawn
  • Advanced and/or Metastatic Solid Tumors
  • +2 more
  • (no location specified)
Apr 21, 2020